Q6IB24 (Q6IB24_HUMAN) Homo sapiens (Human)

Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta UniProtKBAFDB90v4InterProInteractive Modelling

150 aa; Sequence (Fasta) ; 11 identical sequences

Available Structures

35 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of full-length farnesylated and methylated KRAS4b in complex with PDE-delta (crys… Heteromer
O43924; P01116;
1-150
FAR;GDP;EDO;
Assess
Crystal structure of the high affinity KRas mutant PDE6D complex Heteromer
O43924; P01116;
1-150
GDP;FAR;SO4;EDO;
Assess
Complex of Arl2 and PDE delta, Crystal Form 2 (native) Heteromer
O43924; Q9D0J4;
2-150
MG;PO4;GDP;
Assess
Complex of Arl2 and PDE delta, Crystal Form 2 (SeMet) Heteromer
O43924; Q9D0J4;
2-150
PO4;MG;BME;GDP;GTP;
Assess
Crystal structure of farnesylated and methylated kras4b in complex with PDE-delta (crystal form II … Heteromer
O43924; P01116;
3-150
FAR;GDP;EDO;
Assess
Structure of fully modified farnesylated Rheb in complex with PDE6D Heteromer
O43924; Q15382;
4-150
GDP;MG;FAR;
Assess
The crystal structure of the RPGR RCC1-like domain in complex with PDE6D Heteromer
O43924; Q92834;
4-150
Assess
Structure of Fully modified geranylgeranylated PDE6C Peptide in complex with PDE6D Heteromer
O43924; P51160;
4-150
GER;
Assess
Complex of Arl2 and PDE delta, Crystal Form 1 Heteromer
O43924; Q9D0J4;
4-150
MG;GTP;
Assess
The crystal Structure PDE delta in complex with (rac)-p9monomer1-150
P59;P69;
Assess
The crystal structure of inhibitor-15 covalently bound to PDE6Dmonomer1-150
8RQ;
Assess
The crystal Structure PDE delta in complex with compound (R, R)-1gmonomer1-150
JAY;
Assess
The crystal Structure PDE delta in complex with R-p9monomer1-150
P59;
Assess
Cocrystal structure of PDE6D bound to NRAS peptidemonomer1-150
FAR;EDO;SO4;
Assess
Crystal structure of PDE6D in complex with Compound-2monomer1-150
EDO;9VO;SO4;
Assess
The crystal structure of PDE6D in complex to Deltasonamide1monomer2-150
DL3;
Assess
Crystal structure of PDE6D Geranylgeranylated cystein complexmonomer2-150
CMT;EDO;GER;
Assess
The crystal structure of PDE6D in complex with rac-S1monomer2-150
1M1;
Assess
The crystal structure of DW-0254 in complex with PDE6Dmonomer2-150
NI;GOL;O7W;EPE;
Assess
The crystal structure of PDE6D in complex with inhibitor-3monomer2-150
NH6;
Assess
Crystal structure of PDE6D in complex with the inhibitor rac-2monomer2-150
1M0;
Assess
Structure of Fully modified farnesylated INPP5E Peptide in complex with PDE6Dmonomer2-150
FAR;
Assess
Crystal structure of PDE6D KRas peptide complex with Compound-1monomer2-150
9TI;SO4;EDO;FAR;
Assess
The crystal structure of Deltarasin in complex with PDE6Dmonomer2-150
O7T;ACY;
Assess
The crystal structure of PDE6D in complex to inhibitor-1monomer2-150
18F;
Assess
The crystal structure of PDE6D in complex to inhibitor-8monomer2-150
9GD;
Assess
Crystal structure of PDE6D bound to HRas peptidemonomer2-150
FAR;CMT;EDO;
Assess
Fragment-based Drug Discovery of inhibitors to block PDEdelta-RAS protein-protein interactionmonomer2-150
8SF;
Assess
Fragment-based Drug Discovery of inhibitors to block PDEdelta-RAS protein-protein interactionmonomer2-150
8SL;
Assess
The crystal structure of PDE6D in the apo statemonomer2-150
NI;EPE;
Assess
Structure of Fully modified farnesylated Rheb Peptide in complex with PDE6Dmonomer2-150
FAR;
Assess
The crystal structure of PDE6D in complex to inhibitor-7monomer2-150
RRQ;
Assess
The crystal structure of PDE6D in complex to inhibitor-4monomer2-150
V98;
Assess
The crystal structure of PDEd in complex with inhibitor-2amonomer2-150
5KP;
Assess
The Crystal structure of PDE6D in complex with the inhibitor (s)-5monomer4-150
17X;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5tb5.1.Bmonomer0.861-150
100.00
Assess